Impact of intermittent versus continuous infusions on central line-associated bloodstream infection risk in haemato-oncology patients: a quasi-experimental study.

A MacPhailA NguyenV CamusM-N ChraïtiE DalexY ChalandonG CathoD BosettiS Masouridi-LevratS HarbarthM-C ZanellaN Buetti

Published in: The Journal of hospital infection (2024)

Interruption of continuous infusions in haemato-oncology patients with a CVC was not associated with a substantial change in CLABSI rates, whether or not an IPA-C was used.

Keyphrases

end stage renal disease
palliative care
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
escherichia coli
gram negative